BG
Bellevue Group Portfolio holdings
AUM
$4.54B
1-Year Return
22.5%
This Quarter Return
-4.41%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$6.21B
AUM Growth
-$804M
(-11%)
Cap. Flow
-$160M
Cap. Flow
% of AUM
-2.57%
Top 10 Holdings %
Top 10 Hldgs %
40.63%
Holding
166
New
10
Increased
38
Reduced
80
Closed
12
Top Buys
| 1 |
Elevance Health
ELV
|
$31.1M |
| 2 |
UnitedHealth
UNH
|
$24.2M |
| 3 |
Cigna
CI
|
$21.5M |
| 4 |
Humana
HUM
|
$20.8M |
| 5 |
Apellis Pharmaceuticals
APLS
|
$10.5M |
Top Sells
| 1 |
Medtronic
MDT
|
$60.3M |
| 2 |
Inspire Medical Systems
INSP
|
$56.9M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$32.8M |
| 4 |
Charles River Laboratories
CRL
|
$16.7M |
| 5 |
Thermo Fisher Scientific
TMO
|
$15M |
Sector Composition
| 1 | Healthcare | 99.13% |
| 2 | Industrials | 0.77% |
| 3 | Energy | 0.04% |
| 4 | Communication Services | 0.01% |
| 5 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Beam Therapeutics
BEAM
$1.84B
| $16.7M | 0.27% |
694,821
-600
| -0.1% | -$14.4K |
|
77
Supernus Pharmaceuticals
SUPN
$2.55B
| $16M | 0.26% |
580,600
-69,656
| -11% | -$1.92M |
|
|
PNT
78
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $15.7M | 0.25% |
2,351,160
+1,094,963
| +87% | +$7.3M |
|
79
Scholar Rock
SRRK
$3.16B
| $15.2M | 0.24% |
2,137,925
-2,100
| -0.1% | -$14.9K |
|
|
80
Inspire Medical Systems
INSP
$2.55B
| $14M | 0.23% |
70,368
-286,652
| -80% | -$56.9M |
|
|
VRNA
81
Verona Pharma
VRNA
$9.18B
| $14M | 0.22% |
856,358
+284,043
| +50% | +$4.63M |
|
82
Generation Bio
GBIO
$39M
| $13.7M | 0.22% |
361,708
-320
| -0.1% | -$12.1K |
|
83
Amgen
AMGN
$151B
| $13M | 0.21% |
48,473
+21,163
| +77% | +$5.69M |
|
84
Regeneron Pharmaceuticals
REGN
$60B
| $12.3M | 0.2% |
14,939
-1,388
| -9% | -$1.14M |
|
85
10x Genomics
TXG
$1.67B
| $12.1M | 0.2% |
294,432
-30,314
| -9% | -$1.25M |
|
86
Natera
NTRA
$23B
| $11.4M | 0.18% |
257,686
+24,911
| +11% | +$1.1M |
|
87
ResMed
RMD
$40B
| $11.3M | 0.18% |
76,696
-21,579
| -22% | -$3.19M |
|
88
Phreesia
PHR
$1.83B
| $10.8M | 0.17% |
579,039
-59,614
| -9% | -$1.11M |
|
89
Omnicell
OMCL
$1.52B
| $10.8M | 0.17% |
239,279
-54,066
| -18% | -$2.44M |
|
90
Fate Therapeutics
FATE
$111M
| $10.3M | 0.17% |
4,851,579
-4,200
| -0.1% | -$8.9K |
|
|
AMED
91
DELISTED
Amedisys
AMED
| $9.94M | 0.16% |
106,387
-127,931
| -55% | -$11.9M |
|
92
Illumina
ILMN
$15.3B
| $9.89M | 0.16% |
74,047
-12,332
| -14% | -$1.65M |
|
|
ONC
93
BeOne Medicines Ltd. American Depositary Shares
ONC
$35.4B
| $9.5M | 0.15% |
53,200
+43,000
| +422% | +$7.68M |
|
94
Doximity
DOCS
$12.8B
| $8.48M | 0.14% |
399,457
-49,122
| -11% | -$1.04M |
|
95
Gilead Sciences
GILD
$140B
| $8.04M | 0.13% |
107,350
-5,300
| -5% | -$397K |
|
96
Mersana Therapeutics
MRSN
$34.8M
| $6.63M | 0.11% |
208,745
-32
| -0% | -$1.02K |
|
97
Teladoc Health
TDOC
$1.36B
| $6.61M | 0.11% |
355,649
-36,615
| -9% | -$681K |
|
|
MTEM
98
DELISTED
Molecular Templates, Inc.
MTEM
| $6.52M | 0.11% |
1,031,613
+282,946
| +38% | +$1.79M |
|
99
AstraZeneca
AZN
$253B
| $5.73M | 0.09% |
84,600
-1,000
| -1% | -$67.7K |
|
100
Dr. Reddy's Laboratories
RDY
$11.8B
| $5.41M | 0.09% |
401,000
-57,500
| -13% | -$776K |
|